Summary.-To investigate the association between medullary carcinoma of the thyroid (MCT) and carcinoembryonic antigen (CEA), we assayed 78 sera from patients with thyroid diseases for CEA, employing the radioimmunoassay of double antibody technique. All 13 sera from patients with MCT had high levels of CEA, ranging from 14 to 170 ng/ml. Increased serum CEA was noted .even in cases of small, localized carcinoma. By contrast, serum CEA levels were normal (below 10 ng/ml) in all other histological types of thyroid carcinoma (33 cases), except for one case of papillary adenocarcinoma. In 32 patients with non-malignant thyroid diseases, with few exceptions serum CEA levels remained within the normal range. The elevated serum levels of CEA in MCT returned to normal after successful operation. Furthermore, very high tissue concentrations of CEA were demonstrated in MCT. The results indicate that CEA is actively produced by MCT, and that its measurement is useful in the diagnosis and management of the disease. It is suggested that the highly specific association of CEA with MCT may well be related to a defect of neural crest origin.
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MEDULLARY carcinoma of the thyroid (MCT) is known to secrete various bioactive substances such as calcitonin, serotonin, histaminase, etc., the unusual properties of which are exploited to establish early diagnosis in high-risk individuals and also to monitor the presence of metastatic disease following surgical treatment (Melvin, Tashjian and Miller, 1972) . On the other hand, carcinoembryonic antigen (CEA), which was first found in colorectal carcinoma by Gold and Freedman (1965) , is now considered to be a tumour-associated foetal antigen lacking specificity for particular tissues (Dykes and King, 1972; Laurence and Neville, 1972a) . This paper describes the presence of CEA at high concentrations in sera and tumour tissues of MCT in contrast with other histological types of thyroid carcinoma.
MATERIALS AND METHODS
Seventy-eight sera were obtained from patients with thyroid disease at the Thyroid Clinic of the Departments of Internal Medicine II and Radiology, Kyoto University Hospital. In all patients a definite diagnosis had been made by histological examination together with routine tests of thyroid function including scintigraphy. Blood samples were withdrawn by venepuncture, and the serum separated shortly thereafter was stored at -20°C until use.
Radioimmunoassay
The assay method employed was the double antibody technique of nonequilibrium system, modified from the methods of Egan et al. (1972) and Laurence et al. (1972b) . One hundred ,ul of serum sample was mixed with 100 ,ul of 5% normal rabbit serum in phosphate-buffered saline (PBS) at pH 7-4 and then with 100 ,ul of anti-CEA * Reprints may be requested from: Satoshi Hamada, M.D., Radioisotope Research Centre, Kyoto University, Kyoto 606, Japan. antiserum diluted 1: 12,000. The mixture was incubated at 37°C for 2 h, and then 100 pul of 1251-CEA solution (60,000 ct/min) wN-as added. After further incubation at 4°C overnight, 100 pu of 300' goat anti-rabbit IgG antiserum in PBS was also added, followed by incubation at 37°C for another 2 h. The mixture was centrifuged at 3000 rev/min for 30 min, and the radioactivity of the precipitate measured to estimate the amount of CEA it contained. The assay was run in duplicate, and was capable of determining CEA in amounts from 4 to 250 ng/ml with a standard deviation of + 1 ng/ml for a mean value of 15 ng/ml. The upper limit of the normal range is 10 ng/ml. The values obtained (Y) were linearly proportional to those by the zirconyl phosphate gel assay (X), as expressed by a regression equation of
Purified CEA was prepared from perchloric acid extracts of colonic adenocarcinoma using sequential gel filtration on Sepharose 4B and Sephadex G-200 followed by preparative disc-gel electrophoresis (Hamada, Ishikawa and Yoshii, 1976) . The preparations obtained were immunologically indistinguishable from that of Gold (kindly supplied by Dr P. Gold). The CEA was labelled wNith 1251 by the chloramine T method. Specific anti-CEA antiserum was prepared after the method of Gold and Freedman (1965) by immunizing rabbits with perchloric acid extracts of the tumour, followed by absorption with normal sera and tissue extracts of colon, lung and liver.
RESULTS
Serum levels and positivities of CEA in various types of thyroid carcinoma are shown in Fig. 1 and Table I. All 13 patients with medullary carcinoma of the thyroid (MCT) showed high levels of CEA, averaging 84 ng/ml. The values in 8 patients with metastases ranged from 14 to 170 ng/ml, averaging 97 ng/ml, while those in 5 patients without metastasis ranged from 48 to 125 ng/ml, averaging 73 ng/ml. By contrast, all 33 patients with other histological types of thyroid carcinoma showed normal levels of CEA except for one case of papillary adenocarcinoma. In these diseases serum CEA remained within the normal range despite the presence of distant metastases.
Serum CEA levels and positivities in patients with nonmalignant thyroid diseases are shown in Fig. 2 and Table I . Only one of 9 patients with adenoma showed a CEA level of 19 ng/ml, and one of 7 patients with chronic thyroiditis showed a marginally elevated value (12 ng/ml). In all 14 patients with hyperthyroidism and 2 with thyroid cysts, the levels remained within the normal range.
Shown in Table II (Dykes and King, 1972; Laurence et al., 1972a,b; Booth et al., 1973; Hansen et al., 1974 (Reynoso et al., 1972 ) and in about half the patients with the other 2 diseases (Dykes and King, 1972; Laurence and Neville, 1972a Early sporadic studies on thyroid diseases showed that a positive CEA result was found in only one out of 9 patients with thyroid carcinoma but in none of 8 patients with adenoma or nodular goitre (Laurence et al., 1972b; Reynoso et al., 1972; Booth et al., 1973) . Quite recently Rochman et al. (1975) reported a more frequent elevation of CEA in their series including 37 patients with thyroid carcinoma, but the positivity was statistically significant only in cases with no previous history of childhood irradiation. In addition, no relationship was noted between levels of CEA and spread or histological appearance of the tumour.
However, the present study has revealed a highly specific association of raised CEA levels with MCT. The positivity obtained is much higher than in gastrointestinal malignancies and is comparable with that in neuroblastoma. Furthermore, the serum levels were in excess of 40 ng/ml in the majority (92%) of patients including those with localized disease. The levels are even greater than those in carcinomata ofthe gastrointestinal tract, bronchus and breast, in which serum CEA above this level is seen in only 12-13% of early and localized lesions and in 56-77% of distant metastases (Laurence et al., 1 972b; Booth et al., 1973) . It may be ascribed to the high content of CEA in the tumour cells and also to abundant blood supply to the endocrine organ. The results indicate that the assay of CEA is very useful in the diagnosis and follow-up of MCT.
In other histological types of thyroid carcinoma studied by us, serum CEA has remained mostly within the normal range, the findings being similar to those previously reported. It is likely, therefore, that the previous studies may include few or no cases of MCT, the incidence of which is 5-10% of thyroid carcinoma (Melvin et al., 1972) .
With few exceptions, h-igh CEA levels were detected in MCT, which originates from the parafollicular cell. Interestingly enough, this cell is thought to be of neural crest origin and hence differs in its embryological derivation from the other parenchymal cells of the thyroid gland (Pearce, 1968; Weichert, 1970) . Furthermore, it was reported that neuroblastoma, another neural crest tumour, showed a positive CEA finding in nearly all cases, and that the mean value was 4-5 ng/ml in the active disease as compared to the normal range of less than 2 5 ng/ml (Reynoso et al., 1972) . The lower level of CEA in the latter condition may well be due to a less rich blood supply to the tissue. It is therefore suggested that the highly specific association of raised CEA in the 2 neoplasmas may be related to a defect of neuroectodermal origin, although further studies should be performed with other neural crest tumours.
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